tiprankstipranks

Peter Alan Chambre Insider Profile

4 Followers
Peter Alan Chambre, Director at Spectris, holds 5.00K shares in UDG Healthcare (Ticker: GB:UDG), holds 6.01K shares in Spectris (Ticker: GB:SXS), holds ― shares in Consort Medical (Ticker: GB:CSRT). Most recently, Peter Alan Chambre Bought ― shares of UDG Healthcare on May 30, 2019 for an estimated value of 35.50K.
tipranks
Peter Alan Chambre

Peter Alan Chambre
Spectris (SXS)
Director

Ranked #33,797 out of 98,909 Corporate Insiders

Profitable Transactions

100%
3 out of 3 Profitable Transactions

Average Return

+10.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

£240K
100.00%
A breakdown of Peter Alan Chambre's holdings

Insider Roles

Spectris
(SXS)
Director
Roles that Peter Alan Chambre holds in companies

Most Profitable Insider Trade

Stock:
Spectris
(SXS)
Rating:Informative Buy
Date:Nov 15, 2016 - Nov 15, 2017
Return:+21.80%
The most profitable trade made by Peter Alan Chambre

Peter Alan Chambre's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Spectris
Nov 15, 2016
Director
Informative Buy
1.08K
£189.10K
UDG
UDG Healthcare
May 30, 2019
Informative Buy
35.50K
£53.95K
CSRT
Consort Medical
~BTGGF
BTG plc
$30.15K
IVO
Touchstone Innovations
Nov 25, 2014
Informative Buy
13.65K
£9.45K
List of latest transactions for each holding click on a transaction to see Peter Alan Chambre's performance on stock

Peter Alan Chambre insider profile FAQ

What is the percentage of profitable transactions made by Peter Alan Chambre?
The percentage of profitable transactions made by Peter Alan Chambre is 100%.
    What is the average return per transaction made by Peter Alan Chambre?
    The average return per transaction made by Peter Alan Chambre is 10.30%.
      What stocks does Peter Alan Chambre hold?
      Peter Alan Chambre holds: GB:SXS, GB:UDG, GB:CSRT, ~BTGGF, GB:IVO stocks.
        What was Peter Alan Chambre’s latest transaction?
        Peter Alan Chambre latest transaction was an Informative Buy of 35.50K.
          What was Peter Alan Chambre's most profitable transaction?
          Peter Alan Chambre’s most profitable transaction was an Informative Buy of GB:SXS stock on November 15, 2016. The return on the trade was 21.80%.
            What is Peter Alan Chambre's role in Spectris?
            Peter Alan Chambre's role in Spectris is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.